<DOC>
	<DOCNO>NCT02731612</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , multicentre , parallel-group study assess cognitive effect lurasidone bipolar I II patient ( manic depression ) remission episode . Participants show cognitive impairment screen visit enrol study randomize baseline visit receive either lurasidone placebo adjunctive therapy 1:1 ratio 6 week .</brief_summary>
	<brief_title>Study Efficacy Lurasidone Cognitive Functioning Bipolar Patients</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>1 . Males female age 19 65 year inclusive . 2 . Diagnostic Statistical Manual Mental Disorder , 5th Edition ( DSM.5 ) diagnosis Bipolar Type I Type II Disorder , without history psychosis . BP II patient must 2 definite period hypomania last 5 year . 3 . All patient must take either mood stabilizer ( i.e . lithium valproate ) ( lamotrigine mood stabilizer acceptable bipolar 2 disorder patient bipolar I disorder ) atypical antipsychotic combination ( two mood stabilizer mood stabilizer plus atypical antipsychotic ) , therapeutic dos , mood stabilization . Those take two atypical antipsychotic exclude . Combinations medication outline , combination lamotrigine 100400 mg daily , combination mood stabilizer plus asenapine 520 mg/day , also permit . 4 . All concomitant medication must stable dose four week prior randomization visit . 5 . Clinically stable last 4 week assess clinical interview . 6 . A Montgomery Asberg Depression Rating Scale ( MADRS ) Young Mania Rating Scale ( YMRS ) score less equal 8 . 7 . Patients show cognitive impairment ( 0.50 SD ) either Wechsler Adult Intelligence ScaleIV ( WAISIV ) Coding subtest , Rey Auditory Verbal Learning Test ( RAVLT ) total learn score trial 1 5 immediate recall , screen visit . 8 . A WAISIV vocabulary scale score &gt; 5 ( equivalent estimate IQ 80 great ) . 9 . A sufficient level English language . 10 . Females postmenopausal least 1 year screen visit ( confirm FSH test ) surgically sterile . 11 . Females childbearing potential take contraceptive pill agree practice effective double barrier method contraception , time signing inform consent last dose study drug , 7 day dose stop , agree completely abstain heterosexual intercourse . 12 . Capability understanding , consent , comply study requirement , study visit , return clinic followup evaluation specify protocol . 1 . A history unstable inadequately treat medical illness include moderate severe brain injury , neurological illness impact cognitive function . Patients personal family history cardiac problem need undergo Electrocardiogram ( EKG ) screen visit , exclude result abnormal . 2 . Patients take procognitive medication , clozapine , tricyclic antidepressant , firstgeneration antipsychotic , cogentin . 3 . Those take two antipsychotic . 4 . Anticholinergics stimulant increase dopamine level permit 5 . Cognitive remediation therapy within 3 month prior entry double blind phase . 6 . Neuromodulation treatment Electroconvulsive Therapy ( ECT ) repetitive Transcranial Magnetic Stimulation ( rTMS ) transcranial Direct Current Stimulation ( tDCS ) Deep Brain Stimulation ( DBS ) within eight week treatment experimental drug within 30 day . 7 . History nonresponse intolerance lurasidone . 8 . Psychotic disorder Bipolar Disorder . 9 . Patients currently meet criterion anxiety disorder ( General Anxiety Disorder , Obsessive Compulsive Disorder , Panic disorder , Post Traumatic Stress Disorder ) . 10 . Those documented childhood diagnosis AttentionDeficit/Hyperactivity Disorder ADHD learn disorder . 11 . Axis I diagnosis alcohol/substance abuse dependence within past month . 12 . Significant risk harm self others . 13 . Pregnancy lactation . 14 . Liver function test three time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Cognition</keyword>
	<keyword>Euthymic</keyword>
	<keyword>Lurasidone</keyword>
</DOC>